In this episode, ASOPRS Immediate Past President, Dr. Wendy Lee, moderates a candid roundtable with Drs. Don Kikkawa, John Holds, Evan Black, and Reza Vagefi, as they discuss ACGME accreditation of fellowship training.

The panel weighs external validation, standardized training, and the potential for a new ABO subspecialty certification in the setting of ACGME requirements and some program director concerns about those requirements. Both ACGME accreditation of fellowships and participation in ABO Continuing Certification are two key components of an ABMS-compliant certification.

Whether you're a member or simply invested in the future of oculofacial plastic surgery, this conversation is essential listening.

Moderator: Dr. Deepak Ramesh

Guests: Dr. Rod Rohrich and Dr. John Holds

In the dynamic world of oculofacial plastic surgery, trends come and go, but some principles remain timeless. This post explores the evolution of eyelid surgery, the shift towards natural aesthetics, and the future of oculoplastics based on insights from leading experts in the field.

Moderator:

Cat Burkat, MD FACS (Professor at Univ of Wisconsin-Madison)

Guests

· Dr. Elizabeth Bradley, Associate Professor at the Mayo Clinic, Rochester

· Dr. François Codère Associate Professor from the Université de Montréal in Canada

· Dr. Richard Allen, Professor at Baylor in Texas

In this Surgical Spotlight TOP podcast episode: "Myogenic Ptosis: Is It Really Any Different?", we are diving into a topic that most oculoplastic surgeons encounter—but rarely explore in depth: the surgical management of myogenic ptosis in progressive conditions such as Oculopharyngeal Muscular Dystrophy and Chronic Progressive External Ophthalmoplegia. We'll explore how the natural history of myogenic ptosis may change surgical decision-making. Should timing and the selected procedure be driven not just by the exam—but by disease trajectory? Does earlier onset signal a more aggressive course, pushing us toward more proactive surgery rather than a traditional stepwise approach? And how should we rethink concepts like recurrence, failure, and even surgical success when progression is expected?

Tune in as we discuss the challenge of correcting myogenic ptosis—for today, and where the patient will be years from now.